首页> 外国专利> LIQUID ORAL PHARMACEUTICAL DOSAGE FORM COMPRISING AN HISTAMINE H2-RECEPTOR ANTAGONIST AND AN ANTACID

LIQUID ORAL PHARMACEUTICAL DOSAGE FORM COMPRISING AN HISTAMINE H2-RECEPTOR ANTAGONIST AND AN ANTACID

机译:包含组胺H2受体拮抗剂和抗酸剂的液体口服药物剂型

摘要

The invention relate to a liquid oral pharmaceutical dosage form, comprising a) pharmacologically effective amounts of at least one histamine H2- receptor antagonist in a hydrophobic/lipophilic liquid substantially free from water and b) pharmacologically effective amounts of at least one antacid, wherein a) and b) are physically separated from each other, a package comprising multiple liquid oral dosage forms as well as a method of treating a gastric disease or disorder by use of the liquid oral pharmaceutical dosage form.
机译:本发明涉及液体口服药物剂型,其包含:a)在基本上不含水的疏水/亲脂性液体中的药理学有效量的至少一种组胺H2-受体拮抗剂,和b)药理学有效量的至少一种抗酸剂,其中a )和b)在物理上彼此分开,包括多种液体口服剂型的包装以及通过使用液体口服药物剂型治疗胃部疾病或病症的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号